Evidence map›Paper›PMID 33410099›Full record

ArticleDrug delivery and translational research2021

3-O-Methylquercetin from Achyrocline satureioides-cytotoxic activity against A375-derived human melanoma cell lines and its incorporation into cyclodextrins-hydrogels for topical administration.

Eduarda Doneda, Sara Elis Bianchi, Vanessa Pittol, Tainá Kreutz, Juliete Nathali Scholl, Irene L Ibañez, Candelaria Bracalente, Hebe Durán, Fabrício Figueiró, Fábio Klamt and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eduarda DonedaLaboratório de Desenvolvimento Galênico, Programa de Pós-Graduação Em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 90610-000, Porto Alegre, RS, 2752-607, Brazil.
Sara Elis BianchiLaboratório de Desenvolvimento Galênico, Programa de Pós-Graduação Em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 90610-000, Porto Alegre, RS, 2752-607, Brazil. sara.bianchi@ufrgs.br.ORCID 0000-0002-3759-6587
Vanessa PittolLaboratório de Desenvolvimento Galênico, Programa de Pós-Graduação Em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 90610-000, Porto Alegre, RS, 2752-607, Brazil.
Tainá KreutzLaboratório de Desenvolvimento Galênico, Programa de Pós-Graduação Em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 90610-000, Porto Alegre, RS, 2752-607, Brazil.
Juliete Nathali SchollPrograma de Pós-Graduação Em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Avenida Ramiro Barcelos, 90035-003, Anexo, Porto Alegre, RS, 2600, Brazil.
Irene L IbañezInstituto de Nanociencia Y Nanotecnología Nodo Constituyentes, Comisión Nacional de Energía Atómica, Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) Av. General Paz 1499, B1650KNA, San Martín, Buenos Aires, CNEA, Argentina.
Candelaria BracalenteInstituto de Nanociencia Y Nanotecnología Nodo Constituyentes, Comisión Nacional de Energía Atómica, Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) Av. General Paz 1499, B1650KNA, San Martín, Buenos Aires, CNEA, Argentina.
Hebe DuránInstituto de Nanociencia Y Nanotecnología Nodo Constituyentes, Comisión Nacional de Energía Atómica, Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) Av. General Paz 1499, B1650KNA, San Martín, Buenos Aires, CNEA, Argentina.
Fabrício FigueiróPrograma de Pós-Graduação Em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Avenida Ramiro Barcelos, 90035-003, Anexo, Porto Alegre, RS, 2600, Brazil.
Fábio KlamtPrograma de Pós-Graduação Em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Avenida Ramiro Barcelos, 90035-003, Anexo, Porto Alegre, RS, 2600, Brazil.
Valquiria Linck BassaniLaboratório de Desenvolvimento Galênico, Programa de Pós-Graduação Em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 90610-000, Porto Alegre, RS, 2752-607, Brazil. valquiria.bassani@ufrgs.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3-O-Methylquercetin (3OMQ), a natural 3-O-methylflavonoid, was isolated from Achyrocline satureioides and purified using the high-performance counter current chromatography (HPCCC) on a semi-preparative scale. High-purity 3OMQ (98%) was obtained with excellent recovery (81.8% (w/w)) and good yield (190 mg/100 g of plant). Isolated 3OMQ was evaluated against the A375 human amelanotic melanoma cancer cell line and A375-derived with different degrees of aggressiveness (A375-A7, A375-G10, and A375-PCDNA3). The results showed that 3OMQ reduced the cell viability of all strains, demonstrating time- and dose-dependent responses. 3OMQ was used to obtain hydrogels for the topical treatment of melanoma. Thus, 3OMQ was incorporated into hypromellose hydrogels with/without different cyclodextrins (CDs). The 3OMQ formulations showed permeation/retention in all skin layers, namely stratum corneum, epidermis, and dermis. A significant amount of 3OMQ was found in the replication site of the melanoma cells (epidermis and dermis). Altogether, these results demonstrate that 3OMQ can be isolated from Achyrocline satureioides by HPCCC on a semi-preparative scale and exhibit cytotoxic activity against melanoma cells. Its incorporation into an HPMC hydrogel containing HP-β-CD yielded a formulation with excellent technological and biopharmaceutical characteristics for evaluating the topical management of melanoma.

Indexed as

AchyroclineCyclodextrinsMelanomaAdministration, TopicalCell LineHumansHydrogelsPlant ExtractsQuercetin3-methylquercetinCyclodextrinsHydrogelsPlant ExtractsQuercetin3-O-MethylquercetinAchyrocline satureioidesCyclodextrinsHigh-performance counter current chromatographyMelanoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.